A population-based cohort study including 2427 participants found that the prevalence of any aPL at a single time point was 14.5%, and positive aCL IgA and aβ2GPI IgA were independently associated with future atherosclerotic cardiovascular disease (ASCVD) events (12). This evidence concerns the gene CD79A and atherosclerosis.